Sanjiv Patel Relay Therapeutics, Inc. (RLAY) insider trading activity

RLAY Quotes by TradingView

Sanjiv Patel is President and CEO of Relay Therapeutics, Inc.. Currently has a direct ownership of 661,041 shares of RLAY, which is worth approximately $4.38 Million. The most recent transaction as insider was on Apr 12, 2022, when has been sold 28,000 shares (Common Stock) at a price of $4.12 per share, resulting in proceeds of $115,360. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 661K
13.62% 3M change
13.72% 12M change
Total Value Held $4.38 Million

Sanjiv Patel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 12 2022
BUY
Exercise of conversion of derivative security
$115,360 $4.12 p/Share
28,000 Added 9.04%
281,740 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$17,174 $26.1 p/Share
658 Added 0.26%
253,740 Common Stock
Feb 16 2021
SELL
Bona fide gift
-
150,000 Reduced 37.21%
253,082 Common Stock

Also insider at

PRTA
PROTHENA CORP PUBLIC LTD CO Healthcare
SP

Sanjiv Patel

President and CEO
South San Francisco, CA

Track Institutional and Insider Activities on RLAY

Follow Relay Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLAY shares.

Notify only if

Insider Trading

Get notified when an Relay Therapeutics, Inc. insider buys or sells RLAY shares.

Notify only if

News

Receive news related to Relay Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RLAY